Evergreen Capital Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.71M Buy
19,590
+3,162
+19% +$303K 0.04% 350
2025
Q4
$1.59M Sell
16,428
-342
-2% -$33.2K 0.04% 360
2025
Q3
$1.61M Buy
16,770
+1,736
+12% +$160K 0.04% 319
2025
Q2
$1.32M Buy
15,034
+818
+6% +$69.4K 0.04% 316
2025
Q1
$1.29M Buy
14,216
+964
+7% +$86.3K 0.04% 300
2024
Q4
$1.07M Sell
13,252
-467
-3% -$40.4K 0.03% 325
2024
Q3
$1.24M Buy
13,719
+2,297
+20% +$193K 0.04% 305
2024
Q2
$907K Buy
11,422
+1,736
+18% +$142K 0.03% 322
2024
Q1
$850K Buy
9,686
+828
+9% +$70.7K 0.03% 317
2023
Q4
$736K Sell
8,858
-2,136
-19% -$163K 0.03% 334
2023
Q3
$869K Sell
10,994
-3,740
-25% -$313K 0.04% 300
2023
Q2
$1.31M Buy
14,734
+4,825
+49% +$415K 0.05% 259
2023
Q1
$805K Buy
9,909
+3,633
+58% +$296K 0.04% 298
2022
Q4
$492K Sell
6,276
-3,344
-35% -$271K 0.02% 373
2022
Q3
$777K Buy
9,620
+4,393
+84% +$395K 0.04% 284
2022
Q2
$473K Sell
5,227
-3,941
-43% -$399K 0.02% 344
2022
Q1
$1.02M Buy
9,168
+2,378
+35% +$251K 0.04% 284
2021
Q4
$702K Sell
6,790
-800
-11% -$92.6K 0.03% 329
2021
Q3
$951K Buy
7,590
+288
+4% +$37.3K 0.04% 282
2021
Q2
$906K Buy
7,302
+413
+6% +$51.9K 0.04% 278
2021
Q1
$814K Buy
6,889
+709
+11% +$83.1K 0.04% 266
2020
Q4
$724K Buy
6,180
+237
+4% +$26.1K 0.04% 252
2020
Q3
$618K Sell
5,943
-50
-0.8% -$5.02K 0.04% 242
2020
Q2
$550K Buy
5,993
+1,113
+23% +$107K 0.04% 234
2020
Q1
$440K Sell
4,880
-242
-5% -$25.7K 0.04% 238
2019
Q4
$581K Buy
5,122
+38
+0.7% +$4.17K 0.05% 222
2019
Q3
$552K Sell
5,084
-193
-4% -$20.1K 0.05% 215
2019
Q2
$514K Buy
5,277
+126
+2% +$11.5K 0.05% 228
2019
Q1
$469K Sell
5,151
-37
-0.7% -$3.31K 0.05% 220
2018
Q4
$472K Buy
5,188
+1,041
+25% +$97.3K 0.05% 214
2018
Q3
$408K Sell
4,147
-33,622
-89% -$3.11M 0.04% 242
2018
Q2
$3.23M Sell
37,769
-490
-1% -$40.9K 0.3% 76
2018
Q1
$3.07M Buy
38,259
+31
+0.1% +$2.56K 0.29% 83
2017
Q4
$3.09M Sell
38,228
-562
-1% -$45K 0.31% 76
2017
Q3
$3.02M Buy
38,790
+1,178
+3% +$97.8K 0.35% 76
2017
Q2
$3.34M Buy
37,612
+2,413
+7% +$203K 0.54% 53
2017
Q1
$2.84M Sell
35,199
-2,748
-7% -$215K 0.59% 52
2016
Q4
$2.7M Sell
37,947
-32
-0.1% -$2.51K 0.52% 62
2016
Q3
$3.28M Sell
37,979
-535
-1% -$46.6K 0.65% 46
2016
Q2
$3.34M Sell
38,514
-815
-2% -$65.9K 0.73% 43
2016
Q1
$2.95M Buy
39,329
+85
+0.2% +$6.4K 0.68% 43
2015
Q4
$3.02M Sell
39,244
-1,520
-4% -$114K 0.72% 41
2015
Q3
$2.73M Buy
40,764
+100
+0.2% +$7.37K 0.71% 47
2015
Q2
$3.01M Sell
40,664
-31,733
-44% -$2.42M 0.74% 52
2015
Q1
$5.65M Sell
72,397
-5,318
-7% -$403K 1.24% 27
2014
Q4
$4.81M Sell
77,715
-1,050
-1% -$72.9K 0.95% 37
2014
Q3
$4.88M Buy
78,765
+979
+1% +$62.2K 0.95% 37
2014
Q2
$4.96M Buy
77,786
+22
+0% +$1.34K 0.98% 32
2014
Q1
$4.79M Sell
77,764
-865
-1% -$50.4K 0.96% 35
2013
Q4
$4.51M Sell
78,629
-220
-0.3% -$12.5K 0.82% 46
2013
Q3
$4.2M Sell
78,849
-25
-0% -$1.34K 0.67% 52
2013
Q2
$4.06M Buy
+78,874
New +$3.9M 0.62% 55

Other funds holding MDT

Evergreen Capital Management's MDT Position: Q1 2026 in Review

Evergreen Capital Management increased its Medtronic (MDT) stake by 19% in Q1 2026, buying an estimated $303K and bringing the position to 19,590 shares worth $1.71M. The position accounts for 0.04% of the portfolio, ranked #350.

Evergreen Capital Management first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.65M in Q1 2015. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Evergreen Capital Management held 19,590 shares of Medtronic worth $1.71M as of Q1 2026.
  • Evergreen Capital Management bought 3,162 Medtronic shares in Q1 2026, an estimated $303K.
  • Medtronic made up 0.04% of Evergreen Capital Management's portfolio in Q1 2026, its #350 holding.
  • Evergreen Capital Management first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
  • Evergreen Capital Management's Medtronic position peaked at $5.65M in Q1 2015.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Evergreen Capital Management's 13F filing for Q1 2026, filed 14 May 2026.